AULTON
Pharmaceutical company · 23 brands · 29 molecules
Ranked #104 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems
Company overview
AULTON is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations across 29 distinct molecules. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Antiinflammatory Agents And Antiinfectives In Combination. DRAP has issued 1 alert involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Top molecules by brand count
Therapeutic classes
Regulatory record
1 alert in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Get the full profile for AULTON
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included